{
  "ticker": "NVU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969574",
  "id": "02969574",
  "pages": 12,
  "price_sensitive": false,
  "date": "20250715",
  "time": "1817",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250715/pdf/06ltp45hf5xy50.pdf",
  "summary": "### **Material Information Summary**  \n\n#### **Capital Raising and Shareholder Meeting Addendum**  \n- **Placement Details**:  \n  - **Total raised**: $2.0M (AUD) via issuance of **36,363,637 shares** at **$0.055/share**.  \n  - **Structure**: Split into:  \n    - **17,947,637 shares** under **Listing Rule 7.1** (Resolution 6).  \n    - **18,416,000 shares** under **Listing Rule 7.1A** (Resolution 7).  \n  - **Expected issue date**: 22 July 2025.  \n\n- **Lead Manager Incentives**:  \n  - **Options issued**:  \n    - **5,000,000 Lead Manager Options** (terms in Schedule 1).  \n    - **5,000,000 Unlisted Options** (terms in Schedule 2).  \n  - **Issue date**: ~15 August 2025.  \n  - **Cash fee**: $120,000 (6% of gross proceeds).  \n\n- **Use of Funds**:  \n  - Development of EMASS semiconductor tech, EyeFly3D\u2122 commercialization, Nanoshield\u2122 Solar trials (Morocco/UAE), and working capital.  \n\n- **Meeting Details**:  \n  - **Date**: 29 July 2025.  \n  - **Voting deadline**: Proxy forms due by **10:00am AWST on 27 July 2025**.  \n\n#### **Key Impacts on Capital Structure**  \n1. **Dilution**: ~36.4M new shares issued (post-placement) + 10M options to lead managers.  \n2. **Voting Exclusions**: Participants in placements/options barred from voting on associated resolutions (6\u20138).  \n\n**Concisely covers material capital, dilution, and voting implications**.",
  "usage": {
    "prompt_tokens": 7893,
    "completion_tokens": 388,
    "total_tokens": 8281,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-15T09:02:12.796932"
}